COMMUNIQUÉS West-GlobeNewswire

Dr. Teresa Montagut Appointed as Clinical Development and Medical Affairs Head at Mesoblast
12/03/2026
NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced the appointment of Teresa Montagut MD, PhD [...]
Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results
11/03/2026
Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025 Ended year with $78.2 million in cash, cash equivalents and short-term investments, runway through 2027 Completed $ [...]
LogicMark, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
11/03/2026
LOUISVILLE, Ky., March 11, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal safety and care economy, [...]
Longeveron Announces Closing of Private Placement of up to $30 Million
11/03/2026
$15 million upfront with a milestone-driven potential additional $15 million related to the Company’s anticipated pivotal clinical trial in Hypoplastic Left Heart Syndrome (HLHS) priced at the market under Nasdaq rules [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
11/03/2026
ZUG, Switzerland, March 11, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to annual equity incentive awards granted to members of the executive committee of the Company. Attachments notification-of-managers [...]
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026
11/03/2026
JUPITER, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (Nasdaq: DYAI), a global biotechnology company focused on [...]
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
11/03/2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, [...]
BioXcel Therapeutics Announces Closing of $8.0 Million Registered Direct Offering
11/03/2026
NEW HAVEN, Conn., March 11, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence to develop transformative medicines in [...]
RadNet, Inc. to Present at the 28th Annual Barclays Global Healthcare Conference on Thursday, March 12th
11/03/2026
LOS ANGELES, March 11, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, today announced that [...]
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
11/03/2026
Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory Alignment for Each Program Planned in 2026 New Research Supports TN-301’s [...]
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2025 Financial Results
11/03/2026
Full Year 2025 Sales Increased to $59.1 Million, Up 2.3%, Compared to $57.8 Million for the Full Year of 2024 Net sales for the year ended December 31, 2025, were $59.1 million, up 2.3% compared to $57.8 million for the [...]
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results
11/03/2026
PLN-101095 Phase 1 data showed deep and durable ongoing responses in checkpoint inhibitor refractory solid tumors PLN-101095 accelerated development plan underway with initiation of Phase 1b indication expansion trial [...]
Rad Source Technologies Announces Configurable Filters for the RS® 2000·Q2 Biological Irradiator
11/03/2026
BUFORD, Ga., March 11, 2026 (GLOBE NEWSWIRE) -- Rad Source Technologies (Rad Source ® ), a global leader in advanced X‑ray solutions for life sciences, today announced the launch of Configurable Filters for the RS ® [...]
Nyxoah Participera à la 36ème Conférence Annuelle Oppenheimer Healthcare MedTech & Services
11/03/2026
Nyxoah Participera à la 36ème Conférence Annuelle Oppenheimer Healthcare MedTech & Services Mont-Saint-Guibert, Belgique – 11 mars 2026, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » [...]
Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
11/03/2026
Nyxoah to Participate in the Oppenheimer 36 th Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgium – March 11, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“ [...]
Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process
11/03/2026
– Base biologic matrix NXT-41 submitted to FDA; on track for anticipated FDA clearance in second half of 2026 and full NXT-41x clearance in 1H27 – – $44.4 million in cash and escrowed proceeds at year-end – – Conference [...]
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
11/03/2026
FHD-909 (LY4050784) Phase 1 dose-escalation advancing as planned, targeting SMARCA4 (BRG1)-mutant cancers with a focus on non-small cell lung cancer (NSCLC) Selective CBP degrader program with potential in ER+ breast [...]
Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation
11/03/2026
-- Issues Statement in Response to DOMA’s Nomination of Director Candidates -- -- No Shareholder Action Required at This Time -- BRISBANE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: [...]
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
11/03/2026
WARREN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today issued a statement from Founder and CEO Dr. Ryan Saadi regarding the company’s progress in [...]

Pages